Bioventus (BVS) Accumulated Depreciation & Amortization (2020 - 2026)

Bioventus (BVS) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 30.51% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (down 30.51% YoY), and the FY2025 full-year result was $5.7 million, down 25.16% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $1.1 million, down from $5.7 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $9.7 million in Q4 2022 and bottomed at $1.1 million in Q1 2026.
• The 5-year median for Accumulated Depreciation & Amortization is $4.4 million (2023), against an average of $4.5 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization tumbled 72.05%; it then soared 198.89% in 2023.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $9.7 million in 2022, then dropped by 9.29% to $8.8 million in 2023, then fell by 13.46% to $7.7 million in 2024, then dropped by 25.16% to $5.7 million in 2025, then tumbled by 80.67% to $1.1 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $1.1 million (Q1 2026), $5.7 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.

Peer Comparison